GluBio Therapeutics Inc

🗓 Founded 2021👥 12 employees💰 Last funded 2022
Biotechnology Research🌐 glubiotx.com
Website LinkedIn
GluBio Therapeutics is a pioneering TPD company dedicated to developing targeted protein degraders for human diseases with unmet medical needs. Founded by seasoned drug developers with deep knowledge and expertise in TPD drug discovery, the company has established a proprietary TPD discovery platform and robust screening capability. GluBio is advancing a diverse pipeline of highly selective small-molecule degraders across multiple therapeutic areas including oncology and immunology. The company has research operations in both San Diego, CA, USA and Shanghai, China.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
2
Frequently asked questions
Who invested in GluBio Therapeutics Inc?
GluBio Therapeutics Inc has 2 investors on record on gritt.io, including 2 early-stage backers.
When did GluBio Therapeutics Inc last raise funding?
The most recent investment in GluBio Therapeutics Inc recorded on gritt.io was in 2022.
When was GluBio Therapeutics Inc founded?
GluBio Therapeutics Inc was founded in 2021.
What industry is GluBio Therapeutics Inc in?
GluBio Therapeutics Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.